Health tech deals

  • CardMedic secures £411,000 Innovate UK grant to transform healthcare communication barriers

    CardMedic, the frontline healthcare language app, has secured £411,000 in funding from Innovate UK's SMART grant programme. The grant will fund a 12-month project, running from April 2025 to March 2026, to scale and integrate an innovative portal transforming how healthcare organisations deliver language services. CardMedic will strengthen its existing solution to create a seamless, [...]

  • Virtual cancer clinic Perci Health raises £3m

    Digital cancer care provider Perci Health has raised £3m in a funding round that exceeded its initial £1.5m goal, bringing its total raised to £7.7m to date, as it looks to expand partnerships with employers and insurers. The company offers AI-powered support for cancer patients via a digital platform, combining technology with input from nurses, [...]

  • Mosanna Therapeutics raises US$80m to develop nasal spray for sleep apnoea

    Mosanna Therapeutics has secured US$80m in Series A funding to advance development of a nasal spray for obstructive sleep apnoea (OSA), a condition where breathing stops and starts during sleep due to a blocked airway. The investment will support Phase II trials of MOS118, a spray used at night which aims to restore natural airway [...]

  • AI medical transcription startup Lyrebird Health raises US$12m at US$50m valuation

    Melbourne-based startup Lyrebird Health has raised US$12m in fresh funding, valuing the two-year-old company at US$50m. Lyrebird Health’s platform generates clinical documentation from doctor–patient conversations, with the company reporting it saves clinicians 6–8 minutes per consultation. Clinical documentation refers to the detailed records healthcare professionals must complete after each patient visit – an administrative task [...]

  • MedTech Innovator selects 65 startups from nearly 1,500 applicants for 2025 accelerator programme

    MedTech Innovator has selected 65 startups for its 2025 accelerator, choosing just four per cent of applicants from a global pool of nearly 1,500. The four-month programme supports early and mid-stage medical device, diagnostic, and digital health companies, which will now compete for a share of US$800,000 in non-dilutive funding. This year’s cohort includes companies [...]

  • Swiss health-tech Aeon raises €8.2m for AI-powered early disease detection platform

    Swiss health-tech company Aeon has secured €8.2m in seed funding to develop what it describes as an advanced platform for early detection and preventive healthcare. The company combines full-body MRI scans, blood biomarkers, and genetic analysis in a single 60-minute check-up, which it claims can detect and predict over 500 diseases and health risks. Unlike [...]

  • Listen: Navigating market access and reimbursement

    Ahead of his panel at the Prix Galien UK Forum on June 5, we speak to Dr Mel Walker about the biggest challenges and opportunities for companies looking to navigate market access in the UK and beyond. The Prix Galien UK Forum, organised by the Galien Foundation, is a premier platform where global industry leaders, policymakers, and innovators [...]

  • kyron.bio raises €5.5m to use glycan engineering for advanced drug design

    Biotechnology company kyron.bio today announced a €5.5 million funding round. The seed funding round was led by HCVC, with the participation of Verve Ventures, Entrepreneur First, Saras Capital, and numerous reputable angel investors. The funds will accelerate the development of kyron.bio’s proprietary glycan-engineering platform, expand the kyron.bio team and fuel preclinical studies. Additionally, the funding [...]

  • Biostate AI closes $12m to bring ‘Netflix model’ to molecular diagnostics

    AI and RNA sequencing company Biostate AI has announced the successful completion of a $12M Series A funding round, led by Accel. The funds will support the company’s mission to unlock affordable and integrated precision medicine, starting with RNA sequencing (RNAseq) services for US-based molecular research. The company’s immediate focus is revolutionising RNAseq accessibility and [...]

  • Huma announces Eckuity Capital partnership and acquires Aluna

    Remote patient monitoring platform Huma Therapeutics has announced two major milestones today (May 16). The company has revealed details of a global partnership agreement with Eckuity Capital to develop next-generation technology infrastructure for the acquisition and launch of digital solutions in healthcare and research. This strategic collaboration aims to provide the resources necessary to advance [...]